scholarly journals The International Workshop on Meibomian Gland Dysfunction: Executive Summary

2011 ◽  
Vol 52 (4) ◽  
pp. 1922 ◽  
Author(s):  
Kelly K. Nichols ◽  
Gary N. Foulks ◽  
Anthony J. Bron ◽  
Ben J. Glasgow ◽  
Murat Dogru ◽  
...  
Keyword(s):  
International Workshop ◽  
Meibomian Gland ◽  
Meibomian Gland Dysfunction ◽  
Executive Summary

scholarly journals The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee

2011 ◽  
Vol 52 (4) ◽  
pp. 1930 ◽  
Author(s):  
J. Daniel Nelson ◽  
Jun Shimazaki ◽  
Jose M. Benitez-del-Castillo ◽  
Jennifer P. Craig ◽  
James P. McCulley ◽  
...  
Keyword(s):  
International Workshop ◽  
Meibomian Gland ◽  
Meibomian Gland Dysfunction

scholarly journals Research progress on meibomian gland dysfunction from 2011 to 2020: a bibliometric and visualized analysis

2021 ◽  
Author(s):  
Qian Liu ◽  
Fangkun Zhao ◽  
Jun Kong
Keyword(s):  
Core Collection ◽  
Web Of Science ◽  
International Workshop ◽  
The United States ◽  
Meibomian Gland ◽  
Research Progress ◽  
Meibomian Gland Dysfunction ◽  
Research Areas ◽  
Visual Science ◽  
The Web

Abstract Background To explore the research areas, hotspots, and progress of meibomian gland dysfunction through bibliometrics. Methods Related publications were retrieved from the Web of Science Core Collection from 2011 to 2020. VOSviewer1.6.16, Citespace.5.7.R2, and GraphPad Prism 8 were used to visualize the distribution of countries, research institutions, journals, authors, keywords, and annual publication numbers in this field. Results A total number of 716 relevant publications were retrieved. The United States and Keio University ranked the first among the countries and organizations with the most publications. Cornea, Investigative Ophthalmology & Visual Science, and Ocular Surface were the top three journals with the highest publication counts and citations. The authors who contributed to this topic mainly formed three clusters which manifested the research areas, and the extracted keywords mainly formed four clusters which manifested the hotspots were explored. Conclusions The research areas and hotspots of meibomian gland dysfunction were as follow: (1) Pathogenesis or potential etiology of meibomian gland dysfunction; (2) Diagnosis of meibomian gland dysfunction; (3) Therapy of meibomian gland dysfunction and the International Workshop`s dedication to it; (4) Epidemiology of meibomian gland dysfunction.

scholarly journals Meibomian gland dysfunction with involutional eyelids malposition

2016 ◽  
Vol 9 (1) ◽  
pp. 5-12 ◽  
Author(s):  
Vitaly V Potemkin ◽  
Vyacheslav V Rakhmanov ◽  
Elena V Ageeva ◽  
Aisa S Alchinova ◽  
Elena V Meshveliani
Keyword(s):  
International Workshop ◽  
Clinical Score ◽  
Lower Eyelid ◽  
Meibomian Gland ◽  
Meibomian Gland Dysfunction ◽  
Control Group ◽  
Lack Of Information ◽  
Clinical Relationship ◽  
Eyelid Malposition ◽  
Meibomian Glands

The state of the ocular surface and visual functions depends on ocular adnexal tissues. Involutional changes of the eyelids and meibomian glands occur with age. There is a lack of information about possible relationship between involutional lower lid malposition and meibomian gland dysfunction. Purpose. To evaluate meibomian glands dysfunction in patients with lower eyelid malposition. Methods. Two groups of patients were enrolled: 26 patients (52 eyelids) with involutional lower eyelid malposition and a control group of 22 patients (44 eyelids) without eyelid malposition. Groups were comparable by age and sex. The clinical examination included general eye examination; evaluation of the degree of the eyelids laxity, signs of retractors dehiscence and clinical score of meibomian gland’s dysfunction (The International Workshop on Meibomian Gland Dysfunction, 2011). Results. Atonic eyelid changes and meibomian gland dysfunction were significantly more expressed in patients with involutional eyelid malposition (р < 0,05). Conclusion. Our study showed an age-independent clinical relationship between involutional lower eyelid malposition and dysfunction of meibomian glands.

scholarly journals The International Workshop on Meibomian Gland Dysfunction: Report of the Clinical Trials Subcommittee

2011 ◽  
Vol 52 (4) ◽  
pp. 2065 ◽  
Author(s):  
Penny A. Asbell ◽  
Fiona J. Stapleton ◽  
Kerstin Wickström ◽  
Esen K. Akpek ◽  
Pasquale Aragona ◽  
...  
Keyword(s):  
Clinical Trials ◽  
International Workshop ◽  
Meibomian Gland ◽  
Meibomian Gland Dysfunction

scholarly journals Proposed Algorithm for Management of Meibomian Gland Dysfunction Based on Noninvasive Meibography

2020 ◽  
Vol 10 (1) ◽  
pp. 65
Author(s):  
Reiko Arita ◽  
Shima Fukuoka ◽  
Motoko Kawashima
Keyword(s):  
International Workshop ◽  
Treatment Options ◽  
Meibomian Gland ◽  
Meibomian Gland Dysfunction ◽  
Ocular Symptoms ◽  
Appropriate Treatment ◽  
Stage Classification ◽  
Surface Staining ◽  
Selection For ◽  
Selection Of

Although the pathophysiology of meibomian gland dysfunction (MGD) remains incompletely understood, many treatment options have recently become available. According to an international workshop report, treatment selection for MGD should be based on a comprehensive stage classification dependent on ocular symptoms, lid margin abnormalities, meibum grade, and ocular surface staining. However, it is often difficult to evaluate all parameters required for such classification in routine clinical practice. We have now retrospectively evaluated therapeutic efficacy in MGD patients who received five types of treatment in the clinic setting: (1) meibocare (application of a warm compress and practice of lid hygiene), (2) meibum expression plus meibocare, (3) azithromycin eyedrops plus meibocare, (4) thermal pulsation therapy plus meibocare, or (5) intense pulsed light (IPL) therapy plus meibocare. Patients in each treatment group were classified into three subsets according to the meiboscore determined by noncontact meibography at baseline. Eyes in the IPL group showed improvement even if the meiboscore was high (5 or 6), whereas meibocare tended to be effective only if the meiboscore was low (1 or 2). The meiboscore may thus serve to guide selection of the most appropriate treatment in MGD patients. Prospective studies are warranted to confirm these outcomes.

Sign in / Sign up

Export Citation Format

Share Document